John obtained his PhD in biochemistry in 1991 from the Laboratory of Molecular Biophysics, Oxford University. In 1995 he joined the group of Benjamin Neel at Harvard Medical School and the Beth Israel Deaconess Medical Center in Boston (USA) as a Leukemia Society of America Junior Research Fellow studying the role of tyrosine phosphatases in cellular signalling. He returned to the UK in 1999 as a Postdoctoral Research Fellow in the laboratory of Mike Waterfield at the Ludwig Institute for Cancer Research, working on ErbB receptor signalling in cancer and the development and application of proteomic technologies. In 2002, he was appointed Assistant Member of the Institute and Leader of the Cancer Proteomics Group. He moved to the University College London Institute for Women’s Health in 2006 as a Lecturer, establishing an independent group specialising in the application of proteomics to cancer research. He was promoted to Reader in 2015. His group’s research activities are focused on elucidating the molecular mechanisms of aberrant signalling in cancer cells and the discovery of cancer biomarkers using proteomic methods and other molecular techniques. He is currently the secretary of the British Society for Proteome Research.
Dr John F. Timms